Ardelyx Stock News

Penny stocks to buy for under $1. The post Penny Stocks Under $1 To Watch In March 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth quarter, compared to $0.31 in

Micro-cap biotech Ardelyx (ARDX) is trading ~11% higher in the pre-market on Wednesday after Jefferies analyst Christopher Howerton upgraded the stock to Buy from Hold citing…

Ardelyx Inc (NASDAQ: ARDX) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1. Analyst Chris Howerton thinks Ardelyx "s

Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI ) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported closing of $11 million public offering. CooTek (Cayman) Inc. (NYSE: CTK ) rose 37% to $0.4387 in pre-market trading after gaining over 36% on Tuesday. Nordstrom, Inc. (NYSE: JWN ) rose 32.1% to $25.81 in pre-market trading after reporting better-than-expected quarterly results. ECMOHO Limited (NASDAQ: MOHO ) rose 28.8% to $0.30 in pre-market trading after jumping 10% on Tuesday. Avenue Therapeutics, Inc. (NASDAQ: ATXI ) rose 26.9% to $0.77 in pre-market trading after jumping 78% on Tuesday. Avenue Therapeutics, last month, announced the outcome of the FDA meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee on IV tramadol. Brickell Biotech, Inc. (NASDAQ: BBI ) rose 26% to $0.2741 in pre-market trading after gaining around 4% on Tuesday.

Penny stocks to buy for under $1. The post Penny Stocks Under $1 To Watch In March 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Ardelyx (ARDX) delivered earnings and revenue surprises of -24% and 48.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Ardelyx press release (ARDX): Q4 GAAP EPS of -$0.31 misses by $0.05.Revenue of $1.03M (-44.4% Y/Y) beats by $0.12M.

WALTHAM, Mass., Feb. 28, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today reported business events and financial…

Ardelyx, Inc. (ARDX) CEO Mike Raab on Q4 2021 Results - Earnings Call Transcript

Ardelyx (ARDX) delivered earnings and revenue surprises of -24% and 48.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

In the last trading session, 3.15 million Ardelyx Inc. (NASDAQ:ARDX) shares changed hands as the company’s beta touched 1.76. With the company’s per share price at $0.79 changed hands at $0.08 or 11.14% during last session, the market valuation stood at $89.94M. ARDX’s last price was a discount, traded about -1068.35% off its 52-week high … Ardelyx Inc. (ARDX): Why Is Stock So Good? Read More »

Ardelyx (NASDAQ:ARDX) is scheduled to announce Q4 earnings results on Monday, February 28th, after market close.The consensus EPS Estimate is -$0.34 (-6.3% Y/Y) and the consensus…

Aerie (AERI) delivered earnings and revenue surprises of 260.29% and 272.10%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?